ClinConnect ClinConnect Logo
Search / Trial NCT00288119

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Launched by CASE WESTERN RESERVE UNIVERSITY · Feb 6, 2006

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Barrett's Esophagus

ClinConnect Summary

This clinical trial is studying how genetics may influence the development of Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC), which are conditions that affect the esophagus, the tube that carries food from the mouth to the stomach. The researchers aim to better understand how certain genetic factors contribute to these conditions and hope to use this knowledge to improve the way we detect, treat, and prevent them. By working together with various institutions, the team will conduct both laboratory and clinical research to find new ways to help patients at risk of these diseases.

To participate in this study, individuals must be 18 years or older or younger with parental consent, and they should either have a confirmed diagnosis of Barrett's esophagus or esophageal adenocarcinoma, or be family members of someone with these conditions. Participants will have the opportunity to contribute to important research that could lead to better outcomes for patients with BE and EAC. They can expect to be involved in a supportive environment where their contribution could make a difference in understanding these serious health issues.

Gender

ALL

Eligibility criteria

  • Eligible cases will be defined as those patients and their family members who meet the following criteria:
  • Barrett's esophagus confirmed by review of pathology and endoscopy report or adenocarcinoma of the esophagus or family members of person with Barrett's esophagus or adenocarcinoma of the esophagus.
  • Male or female age 18 or older at time of enrollment or male or female less than 18 years of age at time of enrollment with parental consent.
  • Ability to give informed consent, if patient is age 18 or older.

About Case Western Reserve University

Case Western Reserve University (CWRU) is a leading research institution located in Cleveland, Ohio, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, CWRU integrates expertise from various fields, including medicine, engineering, and social sciences, to address complex health challenges. The university's clinical trial initiatives are designed to foster the development of novel therapies and interventions, ensuring rigorous scientific methodologies and ethical standards are upheld. CWRU is dedicated to translating research findings into tangible benefits for patients and communities, contributing significantly to the advancement of healthcare practices and policies.

Locations

Rochester, Minnesota, United States

Philadelphia, Pennsylvania, United States

Saint Louis, Missouri, United States

Baltimore, Maryland, United States

Cleveland, Ohio, United States

Seattle, Washington, United States

Chapel Hill, North Carolina, United States

New York, New York, United States

Cleveland, Ohio, United States

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Amitabh Chak, MD

Principal Investigator

University Hospitals Cleveland Medical Center, CWRU, Cleveland, OH

Gary W Falk, MD, MS

Principal Investigator

University of Pennsylvania

William Grady, MD

Principal Investigator

Fred Hutchinson Cancer Research Center, UWMC, Seattle, WA

Nicholas J Shaheen, M.D.

Principal Investigator

University of North Carolina, Chapel Hill

Ganapathy Prasad, M.D.

Principal Investigator

Mayo Clinic

Marcia Canto, M.D.

Principal Investigator

Johns Hopkins University

John Dumont, D.O.

Principal Investigator

University Hospitals Cleveland Medical Center

Prashanthi Thota, M.D.

Principal Investigator

The Cleveland Clinic

Jean Wang, MD

Principal Investigator

Washington University School of Medicine

Julian Abrams, MD

Principal Investigator

Columbia University

Andrew Kaz, MD

Principal Investigator

VA Puget Sound Health Care System

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials